Le informazioni sugli articoli di fonte ISI sono coperte da copyright

Per ulteriori informazioni selezionare i riferimenti di interesse.

1. Aquino-de Jesus, MJ; Anders, C; Miller, G; Sleasman, JW; Goodenow, MM; Andiman, WA
   Genetically and epidemiologically related "non-syncytium-inducing" isolates of HIV-1 display heterogeneous growth patterns in macrophages
   JOURNAL OF MEDICAL VIROLOGY
   
   M.J. Aquino-de Jesus et al., "Genetically and epidemiologically related "non-syncytium-inducing" isolates of HIV-1 display heterogeneous growth patterns in macrophages", J MED VIROL, 61(2), 2000, pp. 171-180
2. Vanham, G; van Tendeloo, V; Willems, B; Penne, L; Kestens, L; Beirnaert, E; Fransen, K; Heyndrickx, L; Zhong, P; Davis, D; Berneman, Z; van der Groen, G; Van Bockstaele, D
   The HIV-2 genotype and the HIV-1 syncytium-inducing phenotype are associated with a lower virus replication in dendritic cells
   JOURNAL OF MEDICAL VIROLOGY
   
   G. Vanham et al., "The HIV-2 genotype and the HIV-1 syncytium-inducing phenotype are associated with a lower virus replication in dendritic cells", J MED VIROL, 60(3), 2000, pp. 300-312
3. Callaway, DS; Ribeiro, RM; Nowak, MA
   Virus phenotype switching and disease progression in HIV-1 infection
   PROCEEDINGS OF THE ROYAL SOCIETY OF LONDON SERIES B-BIOLOGICAL SCIENCES
   
   D.S. Callaway et al., "Virus phenotype switching and disease progression in HIV-1 infection", P ROY SOC B, 266(1437), 1999, pp. 2523-2530
4. BALOTTA C; BAGNARELLI P; VIOLIN M; RIDOLFO AL; ZHOU D; BERLUSCONI A; CORVASCE S; CORBELLINO M; CLEMENTI M; CLERICI M; MORONI M; GALLI M
   HOMOZYGOUS DELTA-32 DELETION OF THE CCR-5 CHEMOKINE RECEPTOR GENE IN AN HIV-1-INFECTED PATIENT
   AIDS
   
   C. Balotta et al., "HOMOZYGOUS DELTA-32 DELETION OF THE CCR-5 CHEMOKINE RECEPTOR GENE IN AN HIV-1-INFECTED PATIENT", AIDS, 11(10), 1997, pp. 67-71
5. LIESNARD C; DELFORGE ML; TCHETCHEROFF M; DEMAERTELAER V; FARBER CM; VANVOOREN JP
   IMPORTANCE OF METHOD IN THE DETERMINATION OF SYNCYTIUM-INDUCING PHENOTYPE OF HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 CLINICAL ISOLATES
   Journal of virological methods
   
   C. Liesnard et al., "IMPORTANCE OF METHOD IN THE DETERMINATION OF SYNCYTIUM-INDUCING PHENOTYPE OF HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 CLINICAL ISOLATES", Journal of virological methods, 64(2), 1997, pp. 137-145
6. JOLLY PE
   REPLICATIVE CHARACTERISTICS OF PRIMARY ISOLATES OF THE HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 IN PERIPHERAL-BLOOD MONONUCLEAR-CELLS, PRIMARY MACROPHAGES AND CD4-CELL LINES( TRANSFORMED T)
   Cellular and molecular biology
   
   P.E. Jolly, "REPLICATIVE CHARACTERISTICS OF PRIMARY ISOLATES OF THE HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 IN PERIPHERAL-BLOOD MONONUCLEAR-CELLS, PRIMARY MACROPHAGES AND CD4-CELL LINES( TRANSFORMED T)", Cellular and molecular biology, 43(7), 1997, pp. 1057-1065
7. NIELSEN C; BRUUN L; MATHIESEN LR; PEDERSEN C; GERSTOFT J
   DEVELOPMENT OF RESISTANCE TO ZIDOVUDINE (ZDV) AND DIDANOSINE (DDL) INHIV FROM PATIENTS IN ZDV, DDL AND ALTERNATING ZDV DDL THERAPY/
   AIDS
   
   C. Nielsen et al., "DEVELOPMENT OF RESISTANCE TO ZIDOVUDINE (ZDV) AND DIDANOSINE (DDL) INHIV FROM PATIENTS IN ZDV, DDL AND ALTERNATING ZDV DDL THERAPY/", AIDS, 10(6), 1996, pp. 625-633
8. STCLAIR MH; HARTIGAN PM; ANDREWS JC; VAVRO CL; SIMBERKOFF MS; HAMILTON JD
   ZIDOVUDINE RESISTANCE, SYNCYTIUM-INDUCING PHENOTYPE, AND HIV DISEASE PROGRESSION IN A CASE-CONTROL STUDY
   Journal of acquired immune deficiency syndromes
   
   M.H. Stclair et al., "ZIDOVUDINE RESISTANCE, SYNCYTIUM-INDUCING PHENOTYPE, AND HIV DISEASE PROGRESSION IN A CASE-CONTROL STUDY", Journal of acquired immune deficiency syndromes, 6(8), 1993, pp. 891-897
9. CLARKE JR; WILLIAMSON JD; MITCHELL DM
   THE BIOLOGICAL PROPERTIES OF HIV-1 ISOLATES FROM THE LUNG - RELATIONSHIP TO DISEASE PROGRESSION
   The American review of respiratory disease
   
   J.R. Clarke et al., "THE BIOLOGICAL PROPERTIES OF HIV-1 ISOLATES FROM THE LUNG - RELATIONSHIP TO DISEASE PROGRESSION", The American review of respiratory disease, 147(4), 1993, pp. 1001-1001